Hetero and the Russian Direct Investment Fund (RDIF), which has been backing the vaccine and marketing it globally, plan to start production of Sputnik V in India at the beginning of 2021, the statement said.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3mftt8e
via IFTTT
Home »
Healthcare/Biotech-Industry-Economic Times
» Russia agrees to produce coronavirus vaccine Sputnik V in India, set to work with Hetero
0 comments:
Post a Comment